Kudzuvine root peptide tabletting and screening mechanism

Abstract

The utility model discloses a kudzuvine root peptide tabletting processing screening mechanism which comprises a vibration base, a buffer spring and a screening disc, the buffer spring is installed at the position between the vibration base and the bottom of the screening disc, the screening disc comprises a bottom disc, a lower screening disc and an upper screening disc, the lower screening disc is installed at the position between the bottom disc and the upper screening disc, and the upper screening disc is installed at the position between the bottom disc and the lower screening disc. The bottom of the chassis is opposite to the vibration base, a stable screen and a flow collecting disc are arranged in the upper screening disc, first screen holes are formed in the surface of the stable screen, flow dividing rods which are evenly distributed are arranged on the inner surface of the flow collecting disc, a flow dividing screen is arranged in the lower screening disc and comprises an inner circular plate and an outer circular screen, and flow dividing grooves are formed in the surface of the inner circular plate; when the kudzu vine root peptide tablet particle products are screened, the kudzu vine root peptide tablet particle products are shunted by the shunting columns in the flow collecting disc, the kudzu vine root peptide tablet particle products in the flow collecting disc fall on the surface of the inner circular plate to be shunted, and the design of shunting the particle products is adopted in the screening process, so that the particle products can be prevented from being crowded and blocked in screen holes.

Description

Technical Field

[0001] The utility model belongs to the technical field of screening devices, and in particular relates to a pueraria peptide tablet processing and screening mechanism. Background Art

[0002] Pueraria root, also known as sweet kudzu root, kudzu vine, and wild kudzu root, has the functions of relieving muscle and fever, clearing rashes, promoting body fluid and quenching thirst, raising yang and stopping diarrhea, promoting blood circulation and activating collaterals, and detoxifying alcohol. Pueraria root contains a variety of flavonoid components and has certain medicinal value. After being made into pueraria root peptide tablets, it is conducive to absorption and utilization, and increases the edible effect. The Chinese invention patent application number is CN200810166945.5, which discloses the preparation method and use of pueraria root peptide. The pueraria root peptide product made from pueraria root is a conventional drug. The shape of pueraria root peptide tablet particles is one of the types of pueraria root peptide products. There is a screening process in the production process of pueraria root peptide tablet particles to screen out particles that do not meet the standard size;

[0003] The screening principle in the production of pueraria peptide tablet granules is that the vibrator vibrates the screen in the screen plate, the pueraria peptide tablet granule products on the screen vibrate, and the pueraria peptide tablet granules that meet the standards fall on the lower screen, so as to achieve the purpose of screening out the granule products that do not meet the standard size; in the above-mentioned screening process, the pueraria peptide tablet granule products are crowded on the screen, and the crowded products are blocked at the sieve holes of the screen, affecting the screening effect of the particles. When screening the pueraria peptide tablet granules, there is a design of diverting the granule products during screening to avoid the problem of the granule products being crowded and blocked in the sieve holes. For this reason, the present application proposes a pueraria peptide tablet processing screening mechanism. Utility Model Content

[0004] The utility model aims to provide a pueraria peptide tablet processing screening mechanism to solve the problem of the design of no diversion granule product in the screening process proposed in the above background technology.

[0005] To achieve the above-mentioned purpose, the utility model provides the following technical solutions: a pueraria peptide tablet processing and screening mechanism, comprising a vibration base, a buffer spring and a screening plate, the buffer spring is installed at a position between the vibration base and the bottom of the screening plate, the screening plate comprises a chassis, a lower screening plate and an upper screening plate, the lower screening plate is installed at a position between the chassis and the upper screening plate, the bottom of the chassis is opposite to the vibration base, a stable screen and a collecting plate are arranged inside the upper screening plate, the surface of the stable screen is provided with a first sieve hole, the inner surface of the collecting plate is provided with evenly distributed diverter rods, the lower screening plate is provided with a diverter screen inside, the diverter screen comprises an inner circular plate and an outer ring screen, the surface of the inner circular plate is provided with a diverter groove, the inner surface of the inner circular plate located in the diverter groove is provided with a second sieve hole, the surface of the inner circular plate opposite to the diverter groove is provided with a guide protrusion, the surface of the inner circular plate is provided with evenly distributed guide blocks, and the interior of the chassis is provided with a fixed screen.

[0006] Preferably, the centers of the bottom plate, lower screening plate and upper screening plate are on the same axis, the centers of the upper screening plate, the stabilizing screen and the collecting plate are on the same axis, the diverter rod is perpendicular to the inner surface of the collecting plate, and the diverter rod is a hollow conical structure that is wide at the top and narrow at the bottom.

[0007] Preferably, evenly distributed diversion columns are provided at the center of the inner circular plate.

[0008] Preferably, the inner circular plate is a cone structure with one end open, and the center of the inner circular plate is narrow and the circular edge is wide.

[0009] Preferably, the second sieve holes are communicated with the diverter trough, the second sieve holes of the inner circular plate are evenly distributed in the diverter trough, and the second sieve holes are elliptical in shape.

[0010] Preferably, the outer ring sieve is provided with sieving holes, and the second sieve holes have the same geometric shape as the sieving holes.

[0011] Preferably, the guide block is a semi-ellipsoidal structure, and the guide block is distributed between adjacent diversion grooves.

[0012] Compared with the prior art, the beneficial effects of the utility model are:

[0013] In the utility model, when the pueraria peptide compressed tablet granule product is screened, the diversion column in the collecting plate diverts the pueraria peptide compressed tablet granule product, and the pueraria peptide compressed tablet granule product in the collecting plate falls on the surface of the inner circular plate for diversion. The design of diverting the granule product during the screening process can avoid the granule product from being crowded and blocked in the sieve holes. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 It is a schematic diagram of the structure of the utility model;

[0015] Figure 2 It is a schematic cross-sectional structure diagram of the lower screening plate of the utility model;

[0016] Figure 3 It is a schematic diagram of the top view of the structure of the stable screen of the utility model;

[0017] Figure 4 It is a schematic diagram of the top view of the collecting plate of the utility model;

[0018] Figure 5 It is a schematic diagram of the top view of the diverter screen of the utility model;

[0019] Figure 6 For the utility model Figure 5 A schematic diagram of the enlarged structure of the middle part A;

[0020] In the figure: 1. Vibrating base; 2. Buffer spring; 3. Chassis; 4. Lower screening plate; 5. Upper screening plate; 6. Diverter screen; 31. Fixed screen; 51. Stable screen; 52. Collecting plate; 61. Inner circular plate; 62. Outer ring screen; 511. First sieve hole; 521. Diverter rod; 611. Diverter column; 612. Diverter slot; 613. Second sieve hole; 614. Guide block; 615. Guide protrusion. DETAILED DESCRIPTION

[0021] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.

[0022] Example

[0023] See also Figures 1 to 6The utility model provides a technical solution: a pueraria peptide tablet processing and screening mechanism, comprising a vibration base 1, a buffer spring 2 and a screening plate, the buffer spring 2 is installed at a position between the vibration base 1 and the bottom of the screening plate, a vibrator is installed on the vibration base 1, and the screening plate is vibrated by mechanical vibration to screen the pueraria peptide tablet granule product. The screening principle is a conventional technical method, and this application will not be described in detail; the screening plate comprises a bottom plate 3, a lower screening plate 4 and an upper screening plate 5, the lower screening plate 4 is installed at a position between the bottom plate 3 and the upper screening plate 5, the bottom of the bottom plate 3 is opposite to the vibration base 1, and a stable screen 51 and a collecting plate 52 are arranged inside the upper screening plate 5, and the stable screen 51 and the collecting plate 52 are arranged inside the upper screening plate 5. The flow plate 52 is combined with the upper screening plate 5 by a conventional method. The surface of the stable screen 51 is provided with a first sieve hole 511. The pueraria peptide tablet granule product falls on the surface of the stable screen 51. The pueraria peptide tablet granule product leaks from the first sieve hole 511 on the stable screen 51. The caliber of the first sieve hole 511 is larger than the pueraria peptide tablet granule product, so that the pueraria peptide tablet granule product can be easily leaked and larger particles that do not meet the standards can be screened out. The inner surface of the collecting plate 52 is provided with evenly distributed diverter rods 521. The pueraria peptide tablet granule product screened off on the stable screen 51 falls into the collecting plate 52 and falls on the diverter screen 6 from the bottom. The diverter rod 521 diverts the fallen pueraria peptide tablet granule. The peptide tablet granule product is prevented from piling up together; a diversion screen 6 is arranged inside the lower screening plate 4, and the diversion screen 6 further screens the pueraria peptide tablet granule product, and the diversion screen 6 comprises an inner circular plate 61 and an outer ring screen 62, and a diversion groove 612 is opened on the surface of the inner circular plate 61, and the pueraria peptide tablet granule product falls on the surface of the inner circular plate 61, and the pueraria peptide tablet granule product is diverted on the surface of the inner circular plate 61, and the pueraria peptide tablet granule product falls into the diversion groove 612 and falls slowly, and the inner surface of the inner circular plate 61 located in the diversion groove 612 is provided with a second sieve hole 613, and the inner circular plate 61 is located in the diversion groove 612. The opposite surface is provided with a guide protrusion 615 The guide protrusion 615 is curved, and the pueraria peptide tablet granule product is guided and limited by the opposing guide protrusion 615. The pueraria peptide tablet granule product falls in the diversion groove 612 in a standard state, that is, the pueraria peptide tablet granule product is directly opposite to the second sieve hole 613, so that the pueraria peptide tablet granule product leaks from the second sieve hole 613. The second sieve hole 613 has the same geometric shape as the pueraria peptide tablet granule product. The surface of the inner circular plate 61 is provided with uniformly distributed guide blocks 614, and the guide blocks 614 are combined and connected with the inner circular plate 61 by conventional methods. A fixed screen 31 is provided inside the chassis 3, and the fixed screen 31 blocks the pueraria peptide tablet granule product that falls through the screening.

[0024] In this embodiment, the centers of the bottom plate 3, the lower screening plate 4 and the upper screening plate 5 are on the same axis, and the centers of the upper screening plate 5, the stable screen 51 and the collecting plate 52 are on the same axis. The diverter rod 521 is perpendicular to the inner surface of the collecting plate 52. The pueraria peptide tablet granule product screened out on the stable screen 51 falls into the collecting plate 52 and falls on the diverter screen 6 from the bottom. The diverter rod 521 diverts the fallen pueraria peptide tablet granule product to prevent the pueraria peptide tablet granule product from piling up. The diverter rod 521 is a hollow conical structure that is wide at the top and narrow at the bottom. The center position of the inner circular plate 61 is provided with evenly distributed diverter columns 611. The concentrated pueraria peptide tablet granule product falls at the center position of the inner circular plate 61. The diverter column 611 diverts the pueraria peptide tablet granule product to disperse it and fall slowly.

[0025] In this embodiment, the inner circular plate 61 is a cone structure with an opening at one end. The center of the inner circular plate 61 is narrow and the circular edge is wide. The second sieve hole 613 is connected to the diverter trough 612. The second sieve holes 613 of the inner circular plate 61 are equidistantly distributed in the diverter trough 612. The second sieve holes 613 are elliptical in shape. The outer ring sieve 62 is provided with sieving holes. The second sieve holes 613 have the same geometric shape as the sieving holes. The pueraria peptide tablet granule product is guided and limited by the opposing guide protrusions 615. The pueraria peptide tablet granule product falls in the diverter trough 612 in a standard state, that is, the pueraria peptide tablet granule product is opposite to the second sieve hole 613, so that the pueraria peptide tablet granule product leaks from the second sieve hole 613.

[0026] In this embodiment, the guide block 614 is a semi-ellipsoidal structure, and the guide block 614 is distributed between adjacent diversion grooves 612. The guide block 614 plays a guiding role, so that the pueraria peptide tablet granule product on the surface of the inner circular plate 61 falls into the diversion groove 612. The spacing between the inner circular plate 61 and the outer ring screen 62 is H, and the spacing H ranges from 5 to 10 mm, so that the pueraria peptide tablet granule product on the surface of the inner circular plate 61 can fall slowly.

[0027] The working principle and use process of this utility model:

[0028] When sieving the pueraria peptide compressed tablet granule product, the pueraria peptide compressed tablet granule product first falls onto the stable screen 51 in the upper sieving plate 5, and the pueraria peptide compressed tablet granule product leaks from the first sieve hole 511, completing the screening of larger particles that do not meet the standards;

[0029] Then, the pueraria peptide tablet granule product falls into the collecting plate 52, and then falls onto the diversion screen 6 from the bottom. The diversion rod 521 diverts the falling pueraria peptide tablet granule product to prevent the pueraria peptide tablet granule product from piling up.

[0030] The pueraria peptide tablet granules in the collecting plate 52 fall on the surface of the inner circular plate 61. The shunt column 611 shunts the pueraria peptide tablet granules on the surface of the inner circular plate 61, so that the shunt column 611 shunts the pueraria peptide tablet granules, disperses them and falls into the inside of the shunt slot 612 and falls slowly.

[0031] The pueraria peptide compressed tablet granule product is guided and limited by the opposing guide protrusions 615, and the pueraria peptide compressed tablet granule product falls in the diversion groove 612 in a standard state, that is, the pueraria peptide compressed tablet granule product is directly opposite to the second sieve hole 613, so that the pueraria peptide compressed tablet granule product leaks from the second sieve hole 613;

[0032] The standard pueraria peptide tablet granule product falls onto the surface of the fixed screen 31, and the qualified pueraria peptide tablet granule product falls from the discharge port on the bottom plate 3 and is collected;

[0033] In summary, when the pueraria peptide compressed tablet granule product is screened, the diversion column 611 in the collecting plate 52 diverts the pueraria peptide compressed tablet granule product, and the pueraria peptide compressed tablet granule product in the collecting plate 52 falls on the surface of the inner circular plate 61 for diversion. The design of diverting the granule product during the screening process can avoid the granule product from being crowded and blocked in the sieve holes.

[0034] Although the embodiments of the present invention have been shown and described (see the above detailed description for details), it will be understood by those skilled in the art that various changes, modifications, substitutions and variations may be made to these embodiments without departing from the principles and spirit of the present invention, and the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A pueraria peptide tableting and screening mechanism, comprising a vibration base (1), a buffer spring (2) and a screening plate, wherein the buffer spring (2) is installed between the vibration base (1) and the bottom of the screening plate, and is characterized in that: The screening plate comprises a bottom plate (3), a lower screening plate (4) and an upper screening plate (5); the lower screening plate (4) is installed between the bottom plate (3) and the upper screening plate (5); the bottom of the bottom plate (3) is opposite to the vibration base (1); a stable screen (51) and a current collecting plate (52) are provided inside the upper screening plate (5); a first screen hole (511) is provided on the surface of the stable screen (51); evenly distributed diverter rods (521) are provided on the inner surface of the current collecting plate (52); and a diverter rod (521) is provided inside the lower screening plate (4). The flow screen (6) comprises an inner circular plate (61) and an outer ring screen (62), a flow diversion groove (612) is provided on the surface of the inner circular plate (61), a second screen hole (613) is provided on the inner surface of the inner circular plate (61) located in the flow diversion groove (612), a guide protrusion (615) is provided on the opposite surface of the inner circular plate (61) located in the flow diversion groove (612), a uniformly distributed guide block (614) is provided on the surface of the inner circular plate (61), and a fixed screen (31) is provided inside the chassis (3).

2. A pueraria peptide tableting and screening mechanism according to claim 1, characterized in that: The centers of the bottom plate (3), the lower screening plate (4) and the upper screening plate (5) are on the same axis, and the centers of the upper screening plate (5), the stabilizing screen (51) and the current collecting plate (52) are on the same axis. The diverter rod (521) is perpendicular to the inner surface of the current collecting plate (52), and the diverter rod (521) is a hollow cone structure that is wide at the top and narrow at the bottom.

3. A pueraria peptide tableting and screening mechanism according to claim 1, characterized in that: Evenly distributed flow dividing columns (611) are provided at the center of the inner circular plate (61).

4. The pueraria peptide tableting and screening mechanism according to claim 1, characterized in that: The inner circular plate (61) is a cone structure with an open end. The inner circular plate (61) is narrow in the center and wide at the edge.

5. The pueraria peptide tableting and screening mechanism according to claim 1, characterized in that: The second sieve holes (613) are in communication with the diverter trough (612); the second sieve holes (613) of the inner circular plate (61) are equidistantly distributed in the diverter trough (612); and the second sieve holes (613) are elliptical in shape.

6. The pueraria peptide tableting and screening mechanism according to claim 1, characterized in that: The outer ring screen (62) is provided with screening holes, and the second screen holes (613) have the same geometric shape as the screening holes.

7. The pueraria peptide tableting and screening mechanism according to claim 1, characterized in that: The guide block (614) is a semi-ellipsoidal structure, and the guide block (614) is distributed between adjacent diversion slots (612).

Images